Cargando…

Development of Biomarkers for Inhibition of SLC6A19 (B(0)AT1)—A Potential Target to Treat Metabolic Disorders

Recent studies have established that dietary protein restriction improves metabolic health and glucose homeostasis. SLC6A19 (B(0)AT1) is the major neutral amino acid transporter in the intestine and carries out the bulk of amino acid absorption from the diet. Mice lacking SLC6A19 show signs of prote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Javed, Kiran, Cheng, Qi, Carroll, Adam J., Truong, Thy T., Bröer, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274964/ https://www.ncbi.nlm.nih.gov/pubmed/30441827 http://dx.doi.org/10.3390/ijms19113597

Ejemplares similares

Novel Chemical Scaffolds to Inhibit the Neutral Amino Acid Transporter B(0)AT1 (SLC6A19), a Potential Target to Treat Metabolic Diseases
por: Yadav, Aditya, et al.
Publicado: (2020)

Mice Lacking the Intestinal and Renal Neutral Amino Acid Transporter SLC6A19 Demonstrate the Relationship between Dietary Protein Intake and Amino Acid Malabsorption
por: Javed, Kiran, et al.
Publicado: (2019)

Maternal heterozygosity of Slc6a19 causes metabolic perturbation and congenital NAD deficiency disorder in mice
por: Cuny, Hartmut, et al.
Publicado: (2022)

Knockout of the Amino Acid Transporter SLC6A19 and Autoimmune Diabetes Incidence in Female Non-Obese Diabetic (NOD) Mice
por: Waters, Matthew F., et al.
Publicado: (2021)

Mice lacking neutral amino acid transporter B(0)AT1 (Slc6a19) have elevated levels of FGF21 and GLP-1 and improved glycaemic control
por: Jiang, Yang, et al.
Publicado: (2015)

Identification and characterization of a novel SNAT2 (SLC38A2) inhibitor reveals synergy with glucose transport inhibition in cancer cells
por: Gauthier-Coles, Gregory, et al.
Publicado: (2022)

ASCT2 (SLC1A5)-Deficient Mice Have Normal B-Cell Development, Proliferation, and Antibody Production
por: Masle-Farquhar, Etienne, et al.
Publicado: (2017)

Unconventional Functions of Amino Acid Transporters: Role in Macropinocytosis (SLC38A5/SLC38A3) and Diet-Induced Obesity/Metabolic Syndrome (SLC6A19/SLC6A14/SLC6A6)
por: Bhutia, Yangzom D., et al.
Publicado: (2022)

Expression of Glutamine Transporter Slc38a3 (SNAT3) During Acidosis is Mediated by a Different Mechanism than Tissue-Specific Expression
por: Balkrishna, Sarojini, et al.
Publicado: (2014)

A GC-MS/Single-Cell Method to Evaluate Membrane Transporter Substrate Specificity and Signaling
por: Fairweather, Stephen J., et al.
Publicado: (2021)

Intrafamilial variability in SLC6A1-related neurodevelopmental disorders
por: Kassabian, Benedetta, et al.
Publicado: (2023)

Corrigendum: Intrafamilial variability in SLC6A1-related neurodevelopmental disorders
por: Kassabian, Benedetta, et al.
Publicado: (2023)

Association Study of the SLC1A2 (rs4354668), SLC6A9 (rs2486001), and SLC6A5 (rs2000959) Polymorphisms in Major Depressive Disorder
por: Rodek, Patryk, et al.
Publicado: (2022)

Current knowledge of SLC6A1-related neurodevelopmental disorders
por: Goodspeed, Kimberly, et al.
Publicado: (2020)

Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma
por: Schrödter, Sarah, et al.
Publicado: (2016)

Quantitative modelling of amino acid transport and homeostasis in mammalian cells
por: Gauthier-Coles, Gregory, et al.
Publicado: (2021)

Impact of Inhibition of Glutamine and Alanine Transport on Cerebellar Glial and Neuronal Metabolism
por: Das, Abhijit, et al.
Publicado: (2022)

SLC6 transporter oligomerization
por: Jayaraman, Kumaresan, et al.
Publicado: (2020)

Intestinal peptidases form functional complexes with the neutral amino acid transporter B(0)AT1
por: Fairweather, Stephen J., et al.
Publicado: (2012)

Characterization of the transporterB(0)AT3 (Slc6a17) in the rodent central nervous system
por: Hägglund, Maria GA, et al.
Publicado: (2013)

SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma
por: Fan, Yongfei, et al.
Publicado: (2022)

A draft conceptual model of SLC6A1 neurodevelopmental disorder
por: Goodspeed, Kimberly, et al.
Publicado: (2023)

Low temperature bacterial expression of the neutral amino acid transporters SLC1A5 (ASCT2), and SLC6A19 (B0AT1)
por: Galluccio, Michele, et al.
Publicado: (2020)

Exploiting the metabolic dependencies of the broad amino acid transporter SLC6A14
por: Dejure, Francesca R., et al.
Publicado: (2020)

Methylation of the SLC6a2 Gene Promoter in Major Depression and Panic Disorder
por: Bayles, Richard, et al.
Publicado: (2013)

The phenotypic presentation of adult individuals with SLC6A1-related neurodevelopmental disorders
por: Johannesen, Katrine M., et al.
Publicado: (2023)

Inhibition of GCN2 Reveals Synergy with Cell-Cycle Regulation and Proteostasis
por: Gauthier-Coles, Gregory, et al.
Publicado: (2023)

B(0)AT2 (SLC6A15) Is Localized to Neurons and Astrocytes, and Is Involved in Mediating the Effect of Leucine in the Brain
por: Hägglund, Maria G. A., et al.
Publicado: (2013)

Amino Acid Transporter SLC6A14 (ATB(0,+)) – A Target in Combined Anti-cancer Therapy
por: Nałęcz, Katarzyna A.
Publicado: (2020)

SLD Results from the Study of Polarized $Z^{0}$ Produced at the SLC
por: Piccolo, M
Publicado: (1993)

SLC6A3 (DAT1) as a Novel Candidate Biomarker Gene for Suicidal Behavior
por: Rafikova, Ekaterina, et al.
Publicado: (2021)

Association study of polymorphisms in the neutral amino acid transporter genes SLC1A4, SLC1A5 and the glycine transporter genes SLC6A5, SLC6A9 with schizophrenia
por: Deng, Xiangdong, et al.
Publicado: (2008)

Patterns of developmental regression and associated clinical characteristics in SLC6A1-related disorder
por: Kalvakuntla, Sanjana, et al.
Publicado: (2023)

The Role of the SLC Transporters Protein in the Neurodegenerative Disorders
por: Aykac, Asli, et al.
Publicado: (2020)

Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer
por: Althobiti, Maryam, et al.
Publicado: (2021)

SLC1A1, SLC16A9, and CNTN3 Are Potential Biomarkers for the Occurrence of Colorectal Cancer
por: Zhou, Jie, et al.
Publicado: (2020)

The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders
por: Thoeringer, C. K., et al.
Publicado: (2008)

Peripheral SLC6A4 Gene Expression in Obsessive-Compulsive Disorder in the Han Chinese Population
Publicado: (2017)

PS41. Hypermethylation of SLC6A4 promoter in psychiatric disorders suppresses its expression.
por: Ikegame, Tempei, et al.
Publicado: (2016)

Identification and targeted management of a neurodegenerative disorder caused by biallelic mutations in SLC5A6
por: Byrne, Alicia B., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e5ksghv3bgi9gv9rlfsc2s0a80